Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy

Maria Luisa Ribeiro, Sandrina G Nunes, José G Cunha-Vaz, Maria Luisa Ribeiro, Sandrina G Nunes, José G Cunha-Vaz

Abstract

Objective: To examine the relationship between microaneurysm (MA) turnover using automated analysis of fundus photographs (RetmarkerDR; Critical Health SA) and development of clinically significant macular edema (CSME) in nonproliferative diabetic retinopathy (NPDR).

Research design and methods: A prospective, monocenter, observational study was designed to follow eyes/patients with type 2 diabetes and NPDR (Early Treatment Diabetic Retinopathy Study levels 20 and 35) with no prior laser treatment for 2 years or until development of CSME. A total of 410 patients, one eye per patient, fulfilled the inclusion/exclusion criteria and were included in the study. Ophthalmologic examinations including best corrected visual acuity, fundus photography, and optical coherence tomography were performed at baseline, 6 months, and at the last study visit (24 months or before laser treatment).

Results: A total of 348 eyes/patients performed the 24-month visit or developed CSME. Of these 348 eyes/patients, 26 developed CSME. HbA1c levels at baseline and MA turnover (i.e., the sum of the MA formation and disappearance rates) computed during the first 6 months of follow-up were found to be independently predictive factors for development of CSME. MA turnover was 11.2 ± 11.2 in the 26 eyes/patients that developed CSME and 5.0 ± 5.2 in the remaining 322 (P < 0.001). Higher MA turnover values correlated with earlier development of CSME. MA turnover predictive values for CSME development were, for the positive predictive value, 20% and for the negative predictive value, 96%.

Conclusions: MA turnover calculated with the RetmarkerDR predicts development of CSME in eyes with NPDR. Low MA turnover values identify well the eyes that are less likely to develop CSME in a 2-year period.

Trial registration: ClinicalTrials.gov NCT00763802.

Figures

Figure 1
Figure 1
CONSORT flow chart.

References

    1. Fong DS, Aiello L, Gardner TW, et al. American Diabetes Association Retinopathy in diabetes. Diabetes Care 2004;27(Suppl. 1):S84–S87
    1. Sinclair AJ, Bayer AJ, Girling AJ, Woodhouse KW. Older adults, diabetes mellitus and visual acuity: a community-based case-control study. Age Ageing 2000;29:335–339
    1. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006;29:2114–2116
    1. Kempen JH, O’Colmain BJ, Leske MC, et al. Eye Diseases Prevalence Research Group The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122:552–563
    1. Hove MN, Kristensen JK, Lauritzen T, Bek T. The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand 2006;84:619–623
    1. Lobo CL, Bernardes RC, Figueira JP, de Abreu JR, Cunha-Vaz JG. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Arch Ophthalmol 2004;122:211–217
    1. Kohner EM, Stratton IM, Aldington SJ, Turner RC, Matthews DR, U.K. Prospective Diabetes Study Group Microaneurysms in the development of diabetic retinopathy (UKPDS 42). Diabetologia 1999;42:1107–1112
    1. Klein R, Meuer SM, Moss SE, Klein BEK. The relationship of retinal microaneurysm counts to the 4-year progression of diabetic retinopathy. Arch Ophthalmol 1989;107:1780–1785
    1. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7–16
    1. Nunes S, Pires I, Rosa A, Duarte L, Bernardes R, Cunha-Vaz J. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica 2009;223:292–297
    1. Early Treatment Diabetic Retinopathy Study research group Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796–1806
    1. Bernardes R, Baptista P, Cunha-Vaz J, Dias J. Multimodal functional and morphological nonrigid image registration. Presented at Image Processing, 2005, ICIP 2005, IEEE International Conference, 29 March–1 April 2005, at the Lam Woo International Conference Centre, Hong Kong Baptist University, Hong Kong
    1. Ferreira J, Bernardes R, Baptista P, Dias J, Cunha-Vaz J. Earmarking retinal changes in a sequence of digital color fundus photographs. Presented at the 3rd European Medical and Biological Engineering Conference, 20–25 November 2005, Prague, Czech Republic
    1. Bernardes R, Nunes S, Pereira I, et al. Computer-assisted microaneurysm turnover in the early stages of diabetic retinopathy. Ophthalmologica 2009;223:284–291
    1. Bernardes R, Santos T, Cunha-Vaz J. Increased-resolution OCT thickness mapping of the human macula: a statistically based registration. Invest Ophthalmol Vis Sci 2008;49:2046–2052
    1. Klein R, Meuer SM, Moss SE, Klein BE. Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol 1995;113:1386–1391
    1. Sharp PF, Olson J, Strachan F, et al. The value of digital imaging in diabetic retinopathy. Health Technol Assess 2003;7:1–119
    1. Goatman KA, Cree MJ, Olson JA, Forrester JV, Sharp PF. Automated measurement of microaneurysm turnover. Invest Ophthalmol Vis Sci 2003;44:5335–5341

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren